BIOMAT Database Logo BIOMAT Database Logo

[Detoxification in withdrawal state in methadone maintenance patients]. 2003

IuP Sivolap, and V A Savchenkov, and B A Aksel'rod, and D A Kubarev, and T O Chichenkov

A comparative study of withdrawal states of 7 methadone maintenance patients and 21 heroin addicts was carried out. The protracted and low predictable course of methadone withdrawal states, along with relatively high resistance to clonidine and other medications, was demonstrated. Similarity of mental disorders, including addictive personality disorders, was found in both groups of patients.

UI MeSH Term Description Entries
D008297 Male Males
D008691 Methadone A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3) Amidone,Biodone,Dolophine,Metadol,Metasedin,Methaddict,Methadone Hydrochloride,Methadose,Methex,Phenadone,Phymet,Physeptone,Pinadone,Symoron,Hydrochloride, Methadone
D009271 Naltrexone Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. Antaxone,Celupan,EN-1639A,Nalorex,Naltrexone Hydrochloride,Nemexin,ReVia,Trexan,EN 1639A,EN1639A
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D009294 Narcotics Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. Analgesics, Narcotic,Narcotic Analgesics,Narcotic,Narcotic Effect,Narcotic Effects,Effect, Narcotic,Effects, Narcotic
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D003627 Data Interpretation, Statistical Application of statistical procedures to analyze specific observed or assumed facts from a particular study. Data Analysis, Statistical,Data Interpretations, Statistical,Interpretation, Statistical Data,Statistical Data Analysis,Statistical Data Interpretation,Analyses, Statistical Data,Analysis, Statistical Data,Data Analyses, Statistical,Interpretations, Statistical Data,Statistical Data Analyses,Statistical Data Interpretations
D006556 Heroin Dependence Strong dependence or addiction, both physiological and emotional, upon HEROIN. Heroin Abuse,Heroin Addiction,Heroin Smoking,Abuse, Heroin,Addiction, Heroin,Dependence, Heroin,Heroin Smokings,Smoking, Heroin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000316 Adrenergic alpha-Agonists Drugs that selectively bind to and activate alpha adrenergic receptors. Adrenergic alpha-Receptor Agonists,alpha-Adrenergic Receptor Agonists,Adrenergic alpha-Agonist,Adrenergic alpha-Receptor Agonist,Receptor Agonists, Adrenergic alpha,Receptor Agonists, alpha-Adrenergic,alpha-Adrenergic Agonist,alpha-Adrenergic Agonists,alpha-Adrenergic Receptor Agonist,Adrenergic alpha Agonist,Adrenergic alpha Agonists,Adrenergic alpha Receptor Agonist,Adrenergic alpha Receptor Agonists,Agonist, Adrenergic alpha-Receptor,Agonist, alpha-Adrenergic,Agonist, alpha-Adrenergic Receptor,Agonists, Adrenergic alpha-Receptor,Agonists, alpha-Adrenergic,Agonists, alpha-Adrenergic Receptor,Receptor Agonist, alpha-Adrenergic,Receptor Agonists, alpha Adrenergic,alpha Adrenergic Agonist,alpha Adrenergic Agonists,alpha Adrenergic Receptor Agonist,alpha Adrenergic Receptor Agonists,alpha-Agonist, Adrenergic,alpha-Agonists, Adrenergic,alpha-Receptor Agonist, Adrenergic,alpha-Receptor Agonists, Adrenergic

Related Publications

IuP Sivolap, and V A Savchenkov, and B A Aksel'rod, and D A Kubarev, and T O Chichenkov
Detoxification from methadone maintenance.
November 1976, JAMA,
IuP Sivolap, and V A Savchenkov, and B A Aksel'rod, and D A Kubarev, and T O Chichenkov
Detoxification from methadone maintenance: the state of the art.
October 1977, The International journal of the addictions,
IuP Sivolap, and V A Savchenkov, and B A Aksel'rod, and D A Kubarev, and T O Chichenkov
Methadone maintenance withdrawal.
January 1972, JAMA,
IuP Sivolap, and V A Savchenkov, and B A Aksel'rod, and D A Kubarev, and T O Chichenkov
Double-blind detoxification of methadone maintenance patients.
January 1975, The International journal of the addictions,
IuP Sivolap, and V A Savchenkov, and B A Aksel'rod, and D A Kubarev, and T O Chichenkov
Voluntary detoxification of patients on methadone maintenance.
January 1973, The International journal of the addictions,
IuP Sivolap, and V A Savchenkov, and B A Aksel'rod, and D A Kubarev, and T O Chichenkov
Detoxification after methadone maintenance treatment.
January 1981, Annals of the New York Academy of Sciences,
IuP Sivolap, and V A Savchenkov, and B A Aksel'rod, and D A Kubarev, and T O Chichenkov
Clonidine in outpatient detoxification from methadone maintenance.
April 1985, Archives of general psychiatry,
IuP Sivolap, and V A Savchenkov, and B A Aksel'rod, and D A Kubarev, and T O Chichenkov
Abrupt withdrawal of maintenance methadone.
September 1971, JAMA,
IuP Sivolap, and V A Savchenkov, and B A Aksel'rod, and D A Kubarev, and T O Chichenkov
State-trait anxiety in methadone maintenance patients.
August 1981, The International journal of the addictions,
IuP Sivolap, and V A Savchenkov, and B A Aksel'rod, and D A Kubarev, and T O Chichenkov
A comparison of residential heroin detoxification patients and methadone maintenance patients.
January 1993, Drug and alcohol review,
Copied contents to your clipboard!